Is Spruce Biosciences, Inc. (SPRB) a Buy, Sell, or Hold?
NASDAQ : SPRB
Spruce Biosciences, Inc. — Institutional Ownership
$47.07 USD
$0.66 (1.42%)
- Volume
- 26.08K
- Average Volume
- 70.76K
- Market Capitalization
- $129.55M
- P/E Ratio
- -1.15
- Dividend Yield
- 0.00%
- Price Target
- $140.00
- Year High
- $240.00
- Year Low
- $7.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.23
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-30 | BlackRock, Inc. | 187.84K | 6.80% |
| 2026-07-27 | Orin Hirschman | 250K | 9.10% |
| 2026-05-15 | Wellington Management Group LLP | 48796.0 | 3.60% |
| 2026-05-15 | Squadron Master Fund LP | 12200.0 | 0.90% |
| 2026-05-15 | Citadel Advisors LLC | 69999.0 | 5.10% |
| 2026-05-15 | Alyeska Investment Group, L.P. | 61670.0 | 4.49% |
| 2026-05-07 | Ikarian Capital, LLC | 121.36K | 4.80% |
| 2026-04-28 | ExodusPoint Capital Management, LP | 22000.0 | 0.80% |
| 2026-02-24 | Integrated Core Strategies (US) LLC | 102.97K | 9.60% |
| 2026-02-18 | Carlyle Holdings I GP Sub L.L.C. | 50893.0 | 4.70% |
| 2026-02-18 | Carlyle Holdings I GP Inc. | 50893.0 | 4.70% |
| 2026-02-18 | The Carlyle Group Inc. | 50893.0 | 4.70% |
| 2026-02-18 | TC Group, L.L.C. | 50893.0 | 4.70% |
| 2026-02-18 | CG Subsidiary Holdings L.L.C. | 50893.0 | 4.70% |
| 2026-02-18 | Carlyle Holdings I L.P. | 50893.0 | 4.70% |
| 2026-02-18 | Abingworth Bioventures VII LP | 50893.0 | 4.70% |
| 2026-02-18 | Abingworth LLP | 50893.0 | 4.70% |
| 2026-02-18 | Carlyle Genesis UK LLC | 50893.0 | 4.70% |
| 2026-02-18 | Carlyle Investment Management L.L.C. | 50893.0 | 4.70% |
| 2026-02-17 | Alyeska Investment Group, L.P. | 61670.0 | 5.79% |
| 2026-02-17 | ADAR1 Capital Management, LLC | 58000.0 | 5.40% |
| 2026-02-17 | Squadron Master Fund LP | 70000.0 | 6.50% |
| 2026-02-17 | Citadel Advisors LLC | 69999.0 | 6.50% |
| 2026-02-10 | Wellington Management Group LLP | 58949.0 | 5.50% |
| 2025-11-24 | Boone Peter David Mr | 68184.0 | 6.40% |
| 2025-11-07 | Ikarian Capital, LLC | 121.36K | 11.40% |
| 2025-10-16 | Citadel Advisors LLC | 109.65K | 9.99% |
| 2025-10-15 | Squadron Master Fund LP | 62000.0 | 5.80% |
| 2025-10-09 | HealthCap VIII GP LLC | 36640.0 | 3.40% |
| 2025-10-09 | HealthCap VIII, L.P. | 36640.0 | 3.40% |
| 2025-10-08 | Ikarian Capital, LLC | 121.36K | 21.60% |
| 2025-08-13 | Radoff Family Foundation | - | 0.00% |
| 2025-08-13 | Rock Springs Capital Management LP | - | 0.00% |
| 2025-02-13 | Rosalind Advisors, Inc. | - | 0.00% |
| 2025-01-10 | RiverVest Venture Partners III (Ohio), LLC | 38251.0 | 0.10% |
| 2025-01-10 | Niall O'Donnell, Ph.D. | 1M | 2.40% |
| 2025-01-10 | RiverVest Venture Fund III (Ohio), L.P. | 38251.0 | 0.10% |
| 2025-01-10 | RiverVest Venture Fund III, L.P. | 720.66K | 0.20% |
| 2025-01-10 | RiverVest Venture Partners III, L.P. | 758.91K | 0.20% |
| 2025-01-10 | RiverVest Venture Partners IV, LLC | 1M | 2.40% |
| 2025-01-10 | RiverVest Venture Partners IV, L.P. | 1M | 2.40% |
| 2025-01-10 | Jay Schmelter | 1.76M | 4.20% |
| 2025-01-10 | RiverVest Venture Fund IV, L.P. | 1M | 2.40% |
| 2025-01-10 | Thomas C. Melzer | 758.91K | 0.20% |
| 2025-01-10 | RiverVest Venture Partners III, LLC | 758.91K | 0.20% |
| 2025-01-10 | John P. McKearn, Ph.D. | 1.76M | 4.20% |
| 2024-10-23 | Steven Salamon | - | 0.00% |
| 2024-10-23 | Rosalind Master Fund L.P. | - | 0.00% |
| 2024-10-23 | Gil Aharon | - | 0.00% |
| 2024-03-28 | Bradley L. Radoff | 2.82M | 6.90% |
| 2024-02-14 | Steven Boyd | 2.23M | 5.48% |
| 2024-02-14 | Armistice Capital, LLC | 2.23M | 5.48% |
| 2024-01-30 | Rosalind Master Fund L.P. | 2.32M | 5.67% |
| 2024-01-30 | Gil Aharon | 2.32M | 5.67% |
| 2024-01-30 | Steven Salamon | 2.32M | 5.67% |
| 2024-01-30 | Gil Aharon | 2.32M | 5.67% |
| 2023-02-27 | Dr. Kush Parmar | 4.14M | 9.97% |
| 2023-02-27 | 5AM Opportunities II, L.P. | 4.14M | 9.97% |
| 2023-02-27 | 5AM Opportunities II (GP), LLC | 4.14M | 9.97% |
| 2023-02-27 | Andrew J. Schwab | 4.14M | 9.97% |
| 2022-02-14 | 2. | 10.0 | 0.00% |
| 2022-02-15 | Rock Springs Capital Master Fund LP | 1.52M | 6.50% |
| 2022-02-14 | 2. | 10.0 | 7.20% |
| 2022-02-14 | 2. | 10.0 | 7.20% |
| 2022-02-15 | Rock Springs Capital Management LP | 1.62M | 6.92% |
| 2022-02-14 | 2. | 10.0 | 0.20% |
| 2022-02-14 | 2. | 10.0 | 7.20% |
| 2022-02-15 | Rock Springs Capital LLC | 1.62M | 6.92% |
| 2022-02-14 | 2. | 10.0 | 0.20% |
| 2022-02-14 | 2. | 10.0 | 7.40% |
| 2021-05-17 | Deerfield Partners, L.P. | 1.42M | 6.09% |
| 2021-05-17 | Deerfield Mgmt, L.P. | 1.42M | 6.09% |
| 2021-05-17 | Company, L.P. | 1.42M | 6.09% |
| 2021-05-17 | James E. Flynn | 1.42M | 6.09% |
| 2021-02-16 | Kenneth Griffin | 10.0 | 7.30% |
| 2021-02-16 | Citadel GP LLC | 10.0 | 7.30% |
| 2021-02-16 | Rock Springs Capital Master Fund LP | 1.58M | 6.83% |
| 2021-02-16 | Rock Springs Capital LLC | 1.63M | 7.03% |
| 2021-02-16 | Rock Springs Capital Management LP | 1.63M | 7.03% |
| 2021-02-16 | Citadel Advisors Holdings LP | 10.0 | 7.30% |
| 2021-02-16 | CALC IV LP | 10.0 | 0.00% |
| 2021-02-16 | Citadel Securities LLC | 10.0 | 0.00% |
| 2021-02-16 | Citadel Securities GP LLC | 10.0 | 0.00% |
| 2021-02-16 | 2. | 10.0 | 7.30% |
| 2021-02-12 | Steve Elms | 1.21M | 5.18% |
| 2021-02-12 | Anne-Mari Paster | 2.16M | 9.30% |
| 2021-02-12 | Omega Fund VI, L.P. | 2.16M | 9.30% |
| 2021-02-12 | Aisling Capital Partners V, LP | 1.21M | 5.18% |
| 2021-02-12 | Aisling Capital Partners V LLC | 1.21M | 5.18% |
| 2021-02-12 | Andrew Schiff | 1.21M | 5.18% |
| 2021-02-12 | Omega Fund VI GP, L.P. | 2.16M | 9.30% |
| 2021-02-12 | Omega Fund VI GP Manager, Ltd. | 2.16M | 9.30% |
| 2021-02-12 | Claudio Nessi | 2.16M | 9.30% |
| 2021-02-12 | Otello Stampacchia | 2.16M | 9.30% |
| 2021-02-12 | Aisling Capital V, LP | 1.21M | 5.18% |
| 2021-02-08 | Abigail P. Johnson | 1.19M | 5.14% |
| 2020-12-18 | HealthCap VIII, L.P. | 2.03M | 8.80% |
| 2020-12-18 | HealthCap VIII GP S.A. | 2.03M | 8.80% |
| 2020-10-26 | 2. | 10.0 | 7.30% |
| 2020-10-26 | 2. | 10.0 | 0.00% |
| 2020-10-26 | 2. | 10.0 | 0.00% |
| 2020-10-26 | 2. | 10.0 | 0.00% |
| 2020-10-26 | 2. | 10.0 | 7.30% |
| 2020-10-26 | 2. | 10.0 | 7.30% |
| 2020-10-26 | 2. | 10.0 | 7.30% |
| 2020-10-19 | Rock Springs Capital LLC | 1.71M | 7.38% |
| 2020-10-19 | Rock Springs Capital Management LP | 1.71M | 7.38% |
| 2020-10-19 | Rock Springs Capital Master Fund LP | 1.67M | 7.21% |
| 2020-10-16 | Novo Holdings A/S | 4.99M | 21.50% |
SPRB Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $87.11 | 766.6K | $66.78M | $48.91M | $736K | $18.61M |
| 2024-12-31 | $31.50 | 536.44K | $16.9M | $38.75M | $2.76M | -$19.09M |
| 2023-12-31 | $219.75 | 500.63K | $110.01M | $96.34M | $4.61M | $18.28M |
| 2022-12-31 | $82.28 | 611.7K | $50.33M | $24.49M | $6.32M | $32.16M |
| 2021-12-31 | $334.50 | 607.4K | $203.17M | $42.75M | $6.53M | $166.96M |
| 2020-12-31 | $1823.25 | 604.77K | $1.1B | $157.15M | $6.38M | $951.87M |
| 2019-12-31 | $1275.00 | 578.85K | $738.04M | $3.92M | $4.44M | $738.56M |
| 2018-12-31 | $1275.00 | 19874 | $25.34M | $4.11M | -$ | $21.23M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54.00 | 2.43M | $131.28M | $96.3M | $2.74M | $37.73M |
| 2026-03-31 | $65.35 | 1.37M | $89.67M | $54.08M | $7.12M | $42.71M |
| 2025-12-31 | $87.11 | 766.6K | $66.78M | $48.91M | $736K | $18.61M |
| 2025-09-30 | $8.95 | 563.07K | $5.04M | $10.67M | $1.35M | -$4.28M |
| 2025-06-30 | $5.48 | 606.29K | $3.32M | $16.39M | $1.82M | -$11.24M |
| 2025-03-31 | $21.75 | 571.28K | $12.43M | $25.62M | $2.3M | -$10.89M |
| 2024-12-31 | $31.50 | 536.44K | $16.9M | $38.75M | $2.76M | -$19.09M |
| 2024-09-30 | $35.63 | 536.93K | $19.13M | $60.06M | $3.23M | -$37.69M |
| 2024-06-30 | $39.83 | 535.12K | $21.31M | $69.68M | $3.69M | -$44.68M |
| 2024-03-31 | $61.50 | 534.25K | $32.86M | $81.15M | $4.15M | -$44.15M |
| 2023-12-31 | $219.75 | 533.39K | $117.21M | $96.34M | $4.61M | $25.48M |
| 2023-09-30 | $169.50 | 529.24K | $89.71M | $98.8M | $5.06M | -$4.03M |